Invesco Ltd. Ptc Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 53,809 shares of PTCT stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,809

Previous 282,810 80.97%

Holding current value

$2.5 Million

Previous $8.65 Million 76.92%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.39 - $37.66 $6.96 Million - $8.62 Million	-229,001 Reduced 80.97%	53,809 $2 Million
Q2 2024 Aug 13, 2024	SELL	$24.69 - $40.12 $538,735 - $875,418	-21,820 Reduced 7.16%	282,810 $8.65 Million
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $206,410 - $273,076	-8,547 Reduced 2.73%	304,630 $8.86 Million
Q4 2023 Feb 12, 2024	BUY	$18.07 - $29.37 $1.89 Million - $3.07 Million	104,451 Added 50.04%	313,177 $8.63 Million
Q3 2023 Nov 13, 2023	BUY	$22.41 - $41.99 $997,894 - $1.87 Million	44,529 Added 27.12%	208,726 $4.68 Million
Q2 2023 Aug 11, 2023	SELL	$40.4 - $59.1 $3.43 Million - $5.02 Million	-84,877 Reduced 34.08%	164,197 $6.68 Million
Q1 2023 May 12, 2023	BUY	$38.16 - $48.86 $1.08 Million - $1.38 Million	28,253 Added 12.79%	249,074 $12.1 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $4.03 Million - $6.58 Million	120,150 Added 119.35%	220,821 $8.43 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $5.71 Million - $7.35 Million	-136,448 Reduced 57.54%	100,671 $5.05 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $4.87 Million - $8.61 Million	190,370 Added 407.22%	237,119 $9.5 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $133,320 - $178,400	4,000 Added 9.36%	46,749 $1.75 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $78,534 - $92,971	-2,221 Reduced 4.94%	42,749 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $197,892 - $239,224	5,347 Added 13.49%	44,970 $1.67 Million
Q2 2021 Aug 17, 2021	BUY	$37.95 - $49.37 $419,005 - $545,094	11,041 Added 38.63%	39,623 $1.68 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $409,780 - $603,463	8,756 Added 44.16%	28,582 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $399,219 - $563,035	8,324 Added 72.37%	19,826 $1.21 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $2,361 - $2,967	-52 Reduced 0.45%	11,502 $537,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $5.12 Million - $6.62 Million	-120,407 Reduced 91.24%	11,554 $586,000
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $4.08 Million - $7.48 Million	125,968 Added 2101.92%	131,961 $5.89 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $11,824 - $18,375	-367 Reduced 5.77%	5,993 $288,000
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $6,087 - $8,670	-180 Reduced 2.75%	6,360 $215,000
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $8.7 Million - $11 Million	-245,539 Reduced 97.41%	6,540 $294,000
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $938,009 - $1.32 Million	33,393 Added 15.27%	252,079 $9.49 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $6.52 Million - $10.2 Million	218,686 New	218,686 $7.51 Million

Others Institutions Holding PTCT

# of Institutions

224

Shares Held

78M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.32B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account